Sylvie Gleises
About Sylvie Gleises
Sylvie Gleises is the Head of Revenue Synergies at Axa XL and serves as the Regional Chief Executive Officer for Axa Art South and West Europe. She has extensive experience in the finance and consulting sectors, and she is also an Independent Board Member at the biotech startup Hemarina.
Work at AXA XL
Sylvie Gleises has served as the Head of Revenue Synergies at AXA XL since 2019. In this role, she focuses on enhancing revenue generation strategies within the division. Prior to this position, she held various roles within AXA, including Vice President of Investor Relations and Deputy Business Support and Development. Her extensive experience at AXA spans multiple years and includes leadership positions that contribute to the company's strategic objectives.
Current Roles and Board Memberships
In addition to her role at AXA XL, Sylvie Gleises serves as an Independent Board Member at Hemarina, a biotech startup specializing in marine oxygen carriers, since July 2019. She has also been a member of the Advisory Board at Arianee, a blockchain-based platform, since 2018. These positions reflect her involvement in both the insurance and biotechnology sectors.
Education and Expertise
Sylvie Gleises holds a Master of Science in European Studies from the London School of Economics, which she completed in 1999. She also studied Finance at ESCP Business School from 1995 to 1998 and briefly attended the University of St. Gallen for finance studies in 1998. Her educational background provides her with a solid foundation in both finance and sociology, contributing to her expertise in strategic business development.
Professional Background
Sylvie Gleises has a diverse professional background, having worked at Roland Berger Strategy Consultants as a Senior Consultant from 2000 to 2006. Her career at AXA began in 2006, where she held several positions, including Executive Assistant to the Chairman and Chief Executive Officer and Managing Director of AXA Art for France, Benelux, and the Middle East. This varied experience has equipped her with a comprehensive understanding of the insurance and consulting industries.
Achievements in Biotech and Insurance
Sylvie Gleises has been actively involved with Hemarina since 2019, contributing to the company's focus on therapeutic and industrial applications of marine oxygen carriers. Her leadership roles at AXA and AXA Art have also positioned her as a key figure in driving revenue and marketing strategies within the insurance sector. Her contributions reflect her commitment to innovation and growth in both industries.